ArticleBiomedical reports2017
Tolvaptan is effective in treating patients with refractory ascites due to cirrhosis.
Toshiyuki Tahara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ArticleBiomedical reports2017
Toshiyuki Tahara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.